Assessment of hepatocyte growth factor in ovarian cancer mortality (Q35156876)

6 August 2017

Assessment of hepatocyte growth factor in ovarian cancer mortality (English)

1 reference

6 August 2017

1 reference

Georgia Chenevix-Trench

2

Georgia Chenevix-Trench

0 references

Jeremy Chien

Jeremy Chien

32

0 references

Estrid Høgdall

Estrid Høgdall

21

0 references

Robert Vierkant

Robert A Vierkant

6

0 references

Susanne Krüger Kjaer

Susanne Krüger Kjær

22

0 references

Joellen M Schildkraut

38

Joellen M Schildkraut

1 reference

6 August 2017

25

Diether Lambrechts

1 reference

6 August 2017

24

Arif B Ekici

1 reference

6 August 2017

12

Jonathan Beesley

1 reference

6 August 2017

41

Fergus J Couch

1 reference

6 August 2017

23

Peter A Fasching

1 reference

6 August 2017

11

Julie M Cunningham

1 reference

6 August 2017

35

Catherine M Phelan

1 reference

6 August 2017

36

Linda E Kelemen

1 reference

6 August 2017

4

Brooke L Fridley

1 reference

6 August 2017

1

Ellen L Goode

1 reference

6 August 2017

3

Lynn C Hartmann

1 reference

6 August 2017

5

Kimberly R Kalli

1 reference

6 August 2017

42

Thomas A Sellers

1 reference

6 August 2017

13

Sharon E Johnatty

1 reference

6 August 2017

27

Claus Høgdall

1 reference

6 August 2017

29

Beth Y Karlan

1 reference

6 August 2017

28

Lene Lundvall

1 reference

6 August 2017

40

Rebecca Sutphen

1 reference

6 August 2017

26

Evelyn Despierre

1 reference

Ovarian Cancer Association Consortium

6 August 2017

43

Ovarian Cancer Association Consortium

1 reference

6 August 2017

8

Kristin L White

1 reference

6 August 2017

Vijayalakshmi Shridhar

39

Vijayalakshmi Shridhar

1 reference

6 August 2017

16

Sebastian M Armasu

1 reference

6 August 2017

9

Gary L Keeney

1 reference

6 August 2017

37

Prema P Peethambaram

1 reference

6 August 2017

33

David J Duggan

1 reference

6 August 2017

18

Hugues Sicotte

1 reference

6 August 2017

19

Michele M Schmidt

1 reference

6 August 2017

Melissa C Larson

7

1 reference

6 August 2017

Trynda N Oberg

10

1 reference

6 August 2017

Xiaoqing Chen

14

1 reference

6 August 2017

Katelyn E Goodman

15

1 reference

6 August 2017

David N Rider

17

1 reference

6 August 2017

Elaine A Elliott

20

1 reference

6 August 2017

Jenny Gross

30

1 reference

6 August 2017

Robert Brown

31

1 reference

6 August 2017

Ya-Yu Tsai

34

1 reference

6 August 2017

1 July 2011

1 reference

Cancer Epidemiology, Biomarkers & Prevention

6 August 2017

1 reference

6 August 2017

20

1 reference

6 August 2017

8

1 reference

6 August 2017

1638-1648

1 reference

Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009).

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Common variants at 19p13 are associated with susceptibility to ovarian cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot"

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

13 July 2018

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Genetic dissection of intermediate phenotypes as a way to discover novel cancer susceptibility alleles

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Risk of ovarian cancer and inherited variants in relapse-associated genes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Inherited determinants of ovarian cancer survival

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Association of genetic variation in mitotic kinases with breast cancer risk

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Role of genetic polymorphisms and ovarian cancer susceptibility

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

HGF/MET signaling in ovarian cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Expression and mutational analysis of MET in human solid cancers

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Multiple loci with different cancer specificities within the 8q24 gene desert

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Genetic variation in the one-carbon transfer pathway and ovarian cancer risk

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

A second generation human haplotype map of over 3.1 million SNPs

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Principal components analysis corrects for stratification in genome-wide association studies

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Haploview: analysis and visualization of LD and haplotype maps

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

KEGG: kyoto encyclopedia of genes and genomes

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Statistical analysis of proliferative index data in clinical trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Testing association between disease and multiple SNPs in a candidate gene

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Multivitamin and alcohol intake and folate receptor alpha expression in ovarian cancer

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Trend tests for case-control studies of genetic markers: power, sample size and robustness

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Survival among U.S. women with invasive epithelial ovarian cancer

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

“BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated WithBRCA1andBRCA2Mutations

16 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

The Effects of Common Genetic Variants in Oncogenes on Ovarian Cancer Survival

16 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

A common coding variant in CASP8 is associated with breast cancer risk

16 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin

16 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

Effect of Epidermal Growth Factor Receptor Expression Level on Survival in Patients with Epithelial Ovarian Cancer

16 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3153603

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion

16 November 2018

1 reference

12 December 2020

Multiple prostate cancer risk variants on 8q24

1 reference

12 December 2020

Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance

1 reference

12 December 2020

BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping

1 reference

12 December 2020

10.1158/1055-9965.EPI-11-0455

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference